However, the identification of increasing numbers of HL patients that are homozygous for p.V37I, or compound heterozygous for p.V37I and other GJB2 pathogenic variants, indicates that p.V37I likely increases the risk of HL, particularly for mild-to-moderate cases [6, 12–15]. The gene discussed is GJB2; the disease is Hodgkins lymphoma.